BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30272306)

  • 41. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
    Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
    Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
    Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
    Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.
    Ying J; Yu X; Ma C; Zhang Y; Dong J
    Mol Med Rep; 2017 Aug; 16(2):1603-1611. PubMed ID: 28627662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.
    Wang YC; Chen YL; Yuan RH; Pan HW; Yang WC; Hsu HC; Jeng YM
    Carcinogenesis; 2010 Sep; 31(9):1516-22. PubMed ID: 20525879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a.
    Liu W; Feng Q; Liao W; Li E; Wu L
    J Cancer; 2021; 12(22):6905-6920. PubMed ID: 34659578
    [No Abstract]   [Full Text] [Related]  

  • 53. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of circular RNA circ_0008450 predicts dismal prognosis in hepatocellular carcinoma and regulates cell proliferation, apoptosis, and invasion via sponging miR-548p.
    Zhang J; Chang Y; Xu L; Qin L
    J Cell Biochem; 2019 Jun; 120(6):9487-9494. PubMed ID: 30556306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.
    Jiang T; Li M; Li Q; Guo Z; Sun X; Zhang X; Liu Y; Yao W; Xiao P
    Oncol Res; 2017 Aug; 25(7):1117-1127. PubMed ID: 28244848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p.
    Liu H; Xue L; Song C; Liu F; Jiang T; Yang X
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2659-2665. PubMed ID: 30086881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SP1-induced upregulation of lncRNA CTBP1-AS2 accelerates the hepatocellular carcinoma tumorigenesis through targeting CEP55 via sponging miR-195-5p.
    Liu LX; Liu B; Yu J; Zhang DY; Shi JH; Liang P
    Biochem Biophys Res Commun; 2020 Dec; 533(4):779-785. PubMed ID: 32988587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway through negatively targeting DNMT3B.
    Gong HL; Tao Y; Mao XZ; Song DY; You D; Ni JD
    Int J Mol Med; 2019 Oct; 44(4):1219-1232. PubMed ID: 31364725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.